the market loves it. Preliminary “data” from 14 patients for a trial that was committed to in 2014. Should expand market size by 30 -40 patients. Trial performed after ema rejection. Love this company.
- Forums
- ASX - By Stock
- CUV
- Ann: Preliminary results from SCENESSE adolescent EPP study
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
3.72%
!
$12.56

Ann: Preliminary results from SCENESSE adolescent EPP study, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.56 |
Change
0.450(3.72%) |
Mkt cap ! $628.5M |
Open | High | Low | Value | Volume |
$12.05 | $12.59 | $12.00 | $1.100M | 89.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 55 | $12.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.56 | 186 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 186 | 12.520 |
3 | 200 | 12.510 |
2 | 171 | 12.500 |
2 | 169 | 12.490 |
3 | 212 | 12.480 |
Price($) | Vol. | No. |
---|---|---|
12.550 | 66 | 4 |
12.560 | 61 | 1 |
12.570 | 372 | 6 |
12.580 | 223 | 5 |
12.590 | 181 | 5 |
Last trade - 14.01pm 29/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |